Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

For cell and gene therapy, a consistent supply of quality starting material is vital that is maintained throughout the ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Learn about the global cell therapy industry in 2022, including players in the space; key licensing deals, and the effect of ...

Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...

The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.

It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...